glioblastoma multiforme
Showing 26 - 50 of 372
Glioblastoma Multiforme, Anaplastic Astrocytoma, Gliosarcoma Trial in Birmingham (M032, Pembrolizumab)
Recruiting
- Glioblastoma Multiforme
- +2 more
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Jan 30, 2023
Astrocytoma, Grades II, III and IV, Glioblastoma Multiforme, Giant Cell Glioblastoma Trial run by the National Cancer Institute
Recruiting
- Astrocytoma, Grades II, III and IV
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 31, 2023
Astrocytoma, Grade IV, Giant Cell Glioblastoma, Glioblastoma Multiforme Trial run by the NCI (Radiation)
Active, not recruiting
- Astrocytoma, Grade IV
- +3 more
- Radiation
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
Astrocytoma, Grade IV, Glioblastoma, Giant Cell Glioblastoma Trial in United States (CYNK-001 systemic and Intra cavity
Recruiting
- Astrocytoma, Grade IV
- +3 more
- CYNK-001 systemic and Intra cavity administration
-
Duarte, California
- +5 more
Jan 20, 2023
Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in Duarte, Chicago (Neural stem cells loaded with an
Completed
- Glioma
- +7 more
- Neural stem cells loaded with an oncolytic adenovirus
-
Duarte, California
- +1 more
Dec 28, 2022
Glioblastoma Multiforme Trial (5-Aminolevulinic Acid)
Not yet recruiting
- Glioblastoma Multiforme
- 5-Aminolevulinic Acid
- (no location specified)
Jan 16, 2023
Glioblastoma, GBM, Glioblastoma Multiforme Trial in Los Angeles, Boston, New York (Nivolumab-Placebo, Nivolumab,
Recruiting
- Glioblastoma
- +3 more
- Nivolumab-Placebo
- +4 more
-
Los Angeles, California
- +3 more
Jan 16, 2023
Malignant Glioma of Brain, Astrocytoma, Malignant Astrocytoma Trial in Detroit (Ad5-yCD/mutTKSR39rep-ADP adenovirus and
Recruiting
- Malignant Glioma of Brain
- +8 more
- Ad5-yCD/mutTKSR39rep-ADP adenovirus and fractionated stereotactic radiosurgery (fSRS)
-
Detroit, MichiganHenry Ford Health System
Jan 9, 2023
Response and Progression in Glioblastoma
Terminated
- Glioblastoma
- Glioblastoma Multiforme
- MRI
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Jan 12, 2023
Glioblastoma Multiforme, Glioma of Brain Trial in Chandler, Phoenix, Scottsdale (Ribociclib, Everolimus)
Completed
- Glioblastoma Multiforme
- Glioma of Brain
-
Chandler, Arizona
- +2 more
Jan 11, 2023
Glioblastoma Multiforme, Glioblastoma, Adult, Glioma of Brain Trial in Geneva (IMA950/Poly-ICLC, IMA950/Poly-ICLC and
Active, not recruiting
- Glioblastoma Multiforme
- +3 more
- IMA950/Poly-ICLC
- IMA950/Poly-ICLC and pembrolizumab
-
Geneva, SwitzerlandUniversity Hospitals of Geneva
Dec 23, 2022
NSCLC, Glioblastoma Multiforme Trial in United States (GLR2007)
Completed
- Non-small Cell Lung Cancer
- Glioblastoma Multiforme
-
Lafayette, Indiana
- +3 more
Dec 21, 2022
High Grade Glioma, Glioblastoma Multiforme Trial in Japan, United States (DSP-0390)
Recruiting
- High Grade Glioma
- Glioblastoma Multiforme
-
San Francisco, California
- +8 more
Dec 16, 2022
Primary Glioblastoma, Glioblastoma Multiforme Trial in Worldwide (2-OHOA, TMZ, RT)
Recruiting
- Primary Glioblastoma
- Glioblastoma Multiforme
- 2-OHOA
- +2 more
-
Angers, France
- +19 more
Dec 13, 2022
Glioblastoma Multiforme Trial in Baltimore (Retifanlimab, Temozolomide, Radiation Therapy)
Recruiting
- Glioblastoma Multiforme
- Retifanlimab
- +2 more
-
Baltimore, MarylandJohns Hopkins Medical Institution
Dec 5, 2022
Glioma, Malignant, High Grade Glioma, Glioblastoma Trial in Tampa (OS2966, Gadoteridol)
Active, not recruiting
- Glioma, Malignant
- +4 more
-
Tampa, FloridaMoffitt Cancer Center
Nov 28, 2022
Adult Diffuse Glioma Based on Deep Learning
Recruiting
- Astrocytoma
- +2 more
- multi-parametric magnetic resonance imaging scan
- Pathology examination
-
Nanjing, Jiangsu, ChinaDepartment of Radiology, the Affiliated Drum Tower Hospital of N
Nov 21, 2022
Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in New York (Bevacizumab)
Recruiting
- Glioblastoma Multiforme
- Anaplastic Astrocytoma
-
New York, New YorkLenox Hill Brain Tumor Center
Nov 10, 2022
Glioblastoma Multiforme Trial in Brno (11C-Methionine PET/CT)
Recruiting
- Glioblastoma Multiforme
- 11C-Methionine PET/CT
-
Brno, Czech Republic, CzechiaMasaryk Memorial Cancer Institute
Nov 3, 2022
Glioblastoma Multiforme Trial in Chapel Hill (CAR.B7-H3T cells infusion)
Recruiting
- Glioblastoma Multiforme
- CAR.B7-H3T cells infusion
-
Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center
Oct 25, 2022
Glioblastoma Multiforme Trial in Toronto (Reduced margin adaptive radiotherapy)
Recruiting
- Glioblastoma Multiforme
- Reduced margin adaptive radiotherapy
-
Toronto, Ontario, CanadaSunnybrook Health Sciences Centre
Oct 19, 2022